Malaria Vaccines
Recombinant adjuvanted vaccine
This page catalogs 1 malaria vaccine product. Mosquirix (RTS,S/AS01) became the first malaria vaccine recommended by WHO in 2021 after decades of development — a milestone in the effort to reduce malaria mortality, particularly among children in sub-Saharan Africa.
Last updated: April 2026.
Malaria Vaccine Catalog
| Trade Name | Generic Designation | Manufacturer | Vaccine Type | Regulatory Status & Year | Key Notes |
|---|---|---|---|---|---|
| Mosquirix (RTS,S/AS01) | Malaria vaccine | GSK | Recombinant + AS01 adjuvant | WHO Recommended, 2021 | First malaria vaccine recommended by WHO |
Sources
Regulatory data sourced from WHO records. Catalog scope informed by Khan, Shaz, The Ultimate Vaccine Timeline.